First HERA Invest agreement signed to support research and development in cross-border health threats

Cecilia Petio is a medical student at Alma Mater Studiorum – University of BolognaThis article is brought to you in association with the European Commission. Today, the Commission, through its Health Emergency Preparedness and Response Authority (HERA) and the European Investment Bank, have signed an agreement worth €20 million with the French biopharmaceutical company Fabentech. This will support the company’s development and deployment of its broad-spectrum therapeutics to combat […]
Go back up

The European Sting – Critical News & Insights on European Politics, Economy, Foreign Affairs, Business & Technology – europeansting.com